Grants Awarded in 2013
Gene Therapy in a Mouse Model of Virus-triggered X-linked lymphoproliferative Disease (XLP1):
Control of Infection and Disease ProgressionPeter Aichele, PhD
University Medical Center Freiburg, University of Freiburg - Freiburg, Germany
Dysregulation of Dendritic Cell Development in Langerhans Cell HistiocytosisMatthew Collin, MD
Newcastle University - Newcastle upon Tyne, United Kingdom
Unraveling the Pathophysiological Role of the BRAFV600E Mutation in Langerhans Cell Histiocytosis (LCH) and its Therapeutical Implications with Murine Models of High Risk LCHMiriam Merad, MD, PhD
Icahn School of Medicine at Mount Sinai - New York, New York USA
Janus Kinase Inhibition as a Novel Treatment for Hemophagocytic LymphohistiocytosisKim E. Nichols, MD
The Children's Hospital of Philadelphia - Philadelphia, Pennsylvania USA
Histiocyte Society Clinical Trials Database System LCH-IV Treatment Protocol StudyHistiocyte Society Executive Board
LCH Study Reference Center - Vienna, Austria
Return to Grant Awards page